Stockscreener 앱 받기
47.60
1.25%
-0.464
전일 마감가:
$48.06
열려 있는:
$48.54
하루 거래량:
908.83K
Relative Volume:
0.29
시가총액:
$6.03B
수익:
$638.78M
순이익/손실:
$-22.66M
주가수익비율:
-272.91
EPS:
-0.1744
순현금흐름:
$122.18M
1주 성능:
+8.50%
1개월 성능:
+37.17%
6개월 성능:
+112.06%
1년 성능:
+245.67%
1일 변동 폭
$45.53
$48.77
1주일 범위
$41.93
$49.50
52주 변동 폭
$11.16
$49.50
10X 제노믹스 Stock (TXG) Company Profile
명칭
10 X Genomics Inc
전화
(925) 401-7300
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, BTSG, TEM, HQY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
47.49 | 6.10B | 638.78M | -22.66M | 122.18M | -0.1744 |
VEEV
Veeva Systems Inc
|
185.94 | 29.17B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.89 | 13.71B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
44.43 | 8.28B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.39 | 7.89B | 1.34B | 230.70M | 440.96M | 2.6695 |
10X 제노믹스 Stock (TXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | 개시 | Piper Sandler | Neutral |
| 2025-02-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-05-01 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-10 | 개시 | Barclays | Overweight |
| 2023-03-31 | 개시 | Stephens | Overweight |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-08-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-07-25 | 개시 | Canaccord Genuity | Buy |
| 2022-07-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-15 | 개시 | William Blair | Outperform |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-07-10 | 개시 | Stifel | Buy |
| 2020-03-05 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-07 | 개시 | BofA/Merrill | Buy |
| 2019-10-07 | 개시 | Cowen | Outperform |
| 2019-10-07 | 개시 | JP Morgan | Overweight |
| 2019-09-24 | 개시 | Evercore ISI | Outperform |
모두보기
10X 제노믹스 주식(TXG)의 최신 뉴스
10x Genomics stock hits 52-week high at 46.35 USD By Investing.com - Investing.com South Africa
10x Genomics stock hits 52-week high at 46.35 USD - Investing.com UK
How 10x Genomics Inc. (TXG) Affects Rotational Strategy Timing - Stock Traders Daily
Bioinformatics Collaboration and Licensing Deals 2019-2026 | Compare Upfronts, Milestones, and Royalties for 1,230+ Deals - GlobeNewswire Inc.
10X Genomics Inc (TXG) Institutional Confidence - TradingKey
10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026 - BioSpace
ETFs Investing in 10x Genomics Inc Class A Stocks - TradingView
10x Genomics to report Q2 2026 results on August 6 - scanx.trade
10x Genomics sets Aug. 6 webcast to discuss second-quarter results - Stock Titan
Top 3 Health Care Stocks That May Implode This Month - Benzinga
TXG Stock Rallies As Wall Street Hikes Price Targets - StocksToTrade
10x Genomics Is Maintained at Buy by Canaccord Genuity - Moomoo
4 Best Genetic Sequencing Stocks for 2026 and How to Invest - The Motley Fool
BofA Securities Adjusts 10x Genomics Price Target to $46 From $30 - Moomoo
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $35.46, Implies 17% Downside - TradingView
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - MSN
10x Genomics Inc. (TXG) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Does 10x Genomics (TXG) Leaving Russell Value Indexes Reframe Its Growth Versus Profitability Story? - Yahoo Finance
TXG Stock Climbs As Wall Street Hikes Price Targets - StocksToTrade
Is 10x Genomics (TXG) Overvalued Following Its Earnings Beat? - Yahoo Finance
10x Genomics stock hits 52-week high at 40.65 USD - Investing.com
10x Genomics stock hits 52-week high at 40.65 USD By Investing.com - Investing.com India
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $32.08, Implies 14% Downside - TradingView
10x Genomics Is Maintained at Equal-Weight by Morgan Stanley - Moomoo
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG) - Yahoo Finance
10x Genomics Is Maintained at Neutral by Citigroup - Moomoo
Price to sales forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
Enterprise value to revenue forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
Enterprise value to EBIT forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
What Does 10x Genomics' (TXG) Russell Value Index Exit Reveal About Its Evolving Investor Base? - simplywall.st
1KJ Forecast — Price Target — Prediction for 2027 - TradingView
Piper Sandler raises 10X Genomics stock price target on clinical pivot - Investing.com UK
10x Genomics stock hits 52-week high at 37.58 USD - Investing.com
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 3000 Value Benchmark - marketscreener.com
10x Genomics Inc Class A Actuals & Estimates (FWB:1KJ) - TradingView
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 3000E Value Benchmark - marketscreener.com
10x Genomics Inc Class A Actuals & Estimates (DUS:1KJ) - TradingView
Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor - Yahoo Finance
Price to earnings forward of 10x Genomics, Inc. – NASDAQ:TXG - TradingView
10x Genomics Inc Class A Actuals & Estimates (MUN:1KJ) - TradingView
Enterprise value to revenue forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10x Genomics Inc Class A Actuals & Estimates (NASDAQ:TXG) - TradingView
Enterprise value to EBIT forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10X Genomics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
10x Genomics Inc Class A Actuals & Estimates (LSE:0A88) - TradingView
Enterprise value to EBITDA forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10x Genomics Inc Class A Actuals & Estimates (BIVA:TXG) - TradingView
Price to sales forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
TXG Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10x genomics CEO Serge Saxonov sells $1.03m in stock By Investing.com - Investing.com Australia
10X 제노믹스 (TXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10X 제노믹스 주식 (TXG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SULIMAN SHEHNAAZ | Director |
Jun 16 '26 |
Sale |
32.63 |
5,723 |
186,756 |
31,722 |
0.12%
2.41%
자본화:
|
볼륨(24시간):